These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20615202)

  • 21. [From "monocolor" karyotype to "multicolor" karyotype: applications of M-Fish in hematology and oncology].
    Jaffray JY; Giollant M; Perissel B; Vago P
    Bull Cancer; 2002 Feb; 89(2):174-80. PubMed ID: 11888857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Application of new FISH techniques for cytogenetic analysis in hematological malignancies].
    Kakazu N; Abe T
    Rinsho Ketsueki; 2002 May; 43(5):316-8. PubMed ID: 12096476
    [No Abstract]   [Full Text] [Related]  

  • 23. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
    Wang HP; Li GX; Qiao ZH; Wang HW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetics and fluorescence in-situ hybridization in detection of hematological malignancies.
    Frenny VJ; Antonella Z; Luisa A; Shah AD; Sheth JJ; Rocchi M
    Indian J Cancer; 2003; 40(4):135-9. PubMed ID: 14716109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microFIND(®) approach to fluorescent in situ hybridization (FISH).
    Zanardi A; Barborini E; Carbone R
    Methods Mol Biol; 2013; 949():433-49. PubMed ID: 23329459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined simultaneous analysis of morphology and fluorescence in situ hybridization as a novel sensitive method for detecting small populations of malignant cells in patients with a high risk of cancer, premalignant lesions, and minimal residual disease].
    Trakhtenberg LIa
    Genetika; 2010 Oct; 46(10):1343-7. PubMed ID: 21254552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microfluidic channel-assisted screening of hematopoietic malignancies.
    Mughal F; Baldock SJ; Karimiani EG; Telford N; Goddard NJ; Day PJ
    Genes Chromosomes Cancer; 2014 Mar; 53(3):255-63. PubMed ID: 24339206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods for identifying and studying genetic alterations in hormone-dependent cancers.
    Saramäki OR; Waltering KK; Visakorpi T
    Methods Mol Biol; 2009; 505():263-77. PubMed ID: 19117150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conventional cytogenetics and FISH evaluation of chimerism after sex-mismatched bone marrow transplantation (BMT) and donor leukocyte infusion (DLI).
    Díez-Martín JL; Llamas P; Gosálvez J; López-Fernández C; Polo N; de la Fuente MS; Buño I
    Haematologica; 1998 May; 83(5):408-15. PubMed ID: 9658724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method.
    Naume B; Borgen E; Tøssvik S; Pavlak N; Oates D; Nesland JM
    Cytotherapy; 2004; 6(3):244-52. PubMed ID: 15203981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorescence in situ hybridization studies using BAC clones of the EVI1 locus in hematological malignancies with 3q rearrangements.
    Madrigal I; Carrió A; Gómez C; Rozman M; Esteve J; Nomdedeu B; Campo E; Costa D
    Cancer Genet Cytogenet; 2006 Oct; 170(2):115-20. PubMed ID: 17011981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid detection of karyotype changes in interphase bone marrow cells by oligonucleotide primed in situ hybridization (PRINS).
    Wilkens L; Komminoth P; Nasarek A; von Wasielewski R; Werner M
    J Pathol; 1997 Apr; 181(4):368-73. PubMed ID: 9196432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breakpoint differentiation in chromosomal aberrations of hematological malignancies: Identification of 33 previously unrecorded breakpoints.
    Heller A; Loncarevic IF; Glaser M; Gebhart E; Trautmann U; Claussen U; Liehr T
    Int J Oncol; 2004 Jan; 24(1):127-36. PubMed ID: 14654949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of malignant cells in multiple myeloma bone marrow with immunoglobulin VH gene probes by fluorescent in situ hybridization and flow cytometry.
    Cao J; Vescio RA; Hong CH; Kim A; Lichtenstein AK; Berenson JR
    J Clin Invest; 1995 Mar; 95(3):964-72. PubMed ID: 7883997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cytogenetics in metaphase and interphase cells for cancer and genetic research, diagnosis and prognosis. Application in tissue sections and cell suspensions.
    Mühlmann M
    Genet Mol Res; 2002 Jun; 1(2):117-27. PubMed ID: 14963837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration of conventional cytogenetics, comparative genomic hybridisation and interphase fluorescence in situ hybridisation for the detection of genomic rearrangements in acute leukaemia.
    McGrattan P; Campbell S; Cuthbert R; Jones FG; McMullin MF; Humphreys M
    J Clin Pathol; 2008 Aug; 61(8):903-8. PubMed ID: 18474541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of the FICTION technique for the simultaneous detection of immunophenotype and chromosomal abnormalities in routinely fixed, paraffin wax embedded bone marrow trephines.
    Korac P; Jones M; Dominis M; Kusec R; Mason DY; Banham AH; Ventura RA
    J Clin Pathol; 2005 Dec; 58(12):1336-8. PubMed ID: 16311361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicolor fluorescence in situ hybridization characterization of cytogenetically polyclonal hematologic malignancies.
    Davidsson J; Paulsson K; Johansson B
    Cancer Genet Cytogenet; 2005 Dec; 163(2):180-3. PubMed ID: 16337865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of submicroscopic deletions vary according to disease entities and chromosomal translocations in hematologic malignancies: investigation by fluorescence in situ hybridization.
    Moon HW; Chang YH; Kim TY; Oh BR; Min HC; Kim BK; Ahn HS; Cho HI; Lee DS
    Cancer Genet Cytogenet; 2007 Jun; 175(2):166-8. PubMed ID: 17556074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.